In contrast to the proposed tumor suppressor role of C/EBPδ, some recent studies show that C/EBPδ over-expression in tumor cells correlates with poor prognosis in glioblastoma and with metastatic disease and reduced disease-specific survival in urothelial carcinoma [37,38]. Here, CEBPD is linked to metastatic neoplasm.